Research News
View articles by month and year
1–6 of 6 articles
-
Women Taking Statins Have Fewer Heart Problems During Anthracycline Chemotherapy
A study found that women who were taking a statin during and after being treated for breast cancer with anthracycline chemotherapy had fewer heart problems than women who weren’t taking a statin.
-
Use of Anthracyclines to Treat Breast Cancer Has Gone Down
A study has found that after 2005, there was a large increase in taxane chemotherapy and a decrease in anthracycline chemotherapy to treat breast cancer in the United States.
-
New Doxorubicin Formula May Be Safer for Heart Than Traditional Formulas
A small study suggests that a new formulation of the chemotherapy medicine doxorubicin may be safer for the heart than traditional formulations.
-
New Technique May Find Heart Damage Earlier
Research suggests that a new way to measure heart damage caused by certain breast cancer treatments may find damage earlier than traditional measurement tests.
-
HER2 and Topo II Status Affects Response to Anthracycline Chemo
A new study suggests that anthracycline-based chemotherapy regimens should be used to treat only HER2-positive breast cancers.
-
New Chemo Meds Improve Survival for Women with Advanced-Stage Disease
Newer chemotherapy medicines and regimens, as well as targeted therapy medicines, are helping women with advanced-stage breast cancer live longer.
1–6 of 6 articles
